CPTx is a biotech platform company dedicated to the development of next-generation antiviral and biodefense solutions. Using advanced DNA manufacturing, nanochassis technology and pharmacokinetic innovations, CPTx is building a robust pipeline targeting a broad spectrum of viral threats. The company builds on more than 15 years of pioneering work in programmable DNA nanofabrication under the leadership of Prof. Hendrik Dietz at the Technical University of Munich. CPTx's leadership team is comprised of some of the world's leading biotech and pharmaceutical companies, and the organization is committed to improving global health through groundbreaking science.
